Financial Controls for Federally Funded Biotech Startups

Federal grant guidance tells a small business what it has to do: segregate restricted funds, document allowable costs, keep an audit trail. It doesn't tell you how to actually run that with three people and no compliance department. Most of what I know about closing that gap didn't come from a textbook. It came from seven years running accounting and controllership functions at the Delaware Valley Industrial Resource Center (DVIRC), an organization that itself receives state and NIST Manufacturing Extension Partnership federal funding, and from two and a half years as CFO at Techamana, a startup with none of DVIRC's infrastructure and all of the same obligations at a smaller scale.

I'm writing this because UNMIRI has applied for an NCI SBIR award, and the framework below is what I'm applying to our own financial operations as we prepare for it, not a theoretical exercise.

The problem with grant-compliance guidance

Uniform Guidance (2 CFR 200) tells you the destination: allowable costs, fund segregation, documentation sufficient to survive an audit. It says almost nothing about the mechanics of getting there when you're a five-person company instead of a university research office with a dedicated grants-management staff. That gap is exactly where small, federally funded life science companies get into trouble: not because they don't understand the rules, but because nobody wrote down how to implement them at their scale.

The framework below has three parts: an audit and control cadence, a systems-implementation approach, and a stakeholder-reporting model. None of them are novel in isolation. What's useful is applying the same discipline ISO 9001 brings to product quality to the financial side of running a federally funded small business — which is also the argument my co-founder Umair and I made for the product itself in an earlier working paper on quality management for FDA Non-Device clinical decision support software. This is the financial-operations half of that same argument.

Component 1: audit and control cadence

At DVIRC, compliance wasn't a once-a-year event bolted onto the fiscal-year close. It was a recurring cadence of internal control reviews tied directly to the organization's state and federal funding streams, each one checking the same handful of things: are restricted funds actually segregated from unrestricted ones, is every cost allocation documented well enough that a stranger could reconstruct it, and does the paper trail hold up if someone outside the organization asks to see it.

The mistake small companies make is treating audit-readiness as something you assemble right before an audit happens. By the time you're preparing for a review, it's too late to fix how the underlying transactions were recorded. The cadence has to run continuously, at a scale that matches the organization: monthly reconciliation of grant-restricted accounts, a documented cost-allocation method decided in advance rather than justified after the fact, and internal control checks frequent enough that a real audit finds nothing it didn't already know about.

Component 2: systems implementation as change control

The clearest example I can point to is leading DVIRC's implementation of Sage Intacct, a cloud-based accounting platform, to replace a legacy system that had accumulated years of manual workarounds. The hard part of that project wasn't the software. It was migrating a live financial system, mid-audit-cycle, without breaking the documentation trail that federal grant compliance depends on.

That's a change-control problem, not just an IT project. Every account mapping, every historical transaction, every reconciliation process had to carry over in a form that stayed auditable through the transition. Get that wrong and you don't just have a rocky software rollout, you have a gap in your compliance record. Get it right, and the payoff compounds: what used to take days of manual reconciliation became something the accounting team could do in a fraction of the time, freeing up real hours for actual financial planning instead of data entry.

The lesson for a company like UNMIRI, sized to run any future federal award on the same kind of small-team financial infrastructure, is to treat any system change touching grant funds as a controlled migration with a documented before-and-after, not a routine upgrade.

Component 3: reporting built for the audience, not the ledger

The other piece of DVIRC's operation I built was a Tableau-based dashboard program for internal and external reporting. The starting point wasn't "what does the general ledger contain." It was "what does this specific stakeholder need to see to make a decision." Internal operational stakeholders needed something different from external funders, and building one universal report that tried to serve both ended up serving neither well.

The dashboards we built instead were purpose-specific: distinct views built around the questions each audience actually asked, using the same underlying data. The consistent feedback was that people found them easier to act on than the reports they replaced, specifically because each dashboard was designed around a stakeholder's decision rather than around what was easiest to pull from the accounting system.

For federal grant reporting specifically, this matters because the audience genuinely differs: a program officer wants to see spend against budget category and milestone progress; an internal team wants to see burn rate and remaining runway. Building both from the same underlying ledger, rather than maintaining two disconnected sets of numbers, is what keeps the reporting itself from becoming a compliance risk.

Applying this at UNMIRI

None of this changes because the organization gets smaller. If anything, a five-person company has less room for error than DVIRC did, because there's no one else to catch a mistake before it becomes a finding. The same three components are what we're building into UNMIRI's own financial operations now, ahead of any award decision on our pending application: a recurring, not once-a-year, control cadence we'd apply to grant-restricted funds if funded; treating any accounting-system change as a controlled migration rather than a routine upgrade; and structuring financial reporting around what a federal program officer and our own team would each need to see, rather than one generic report trying to serve both.

That's the operational half of what it takes to run a federally funded small business well. The other half, keeping the product itself to a defensible quality standard, is what our ISO 9001-aligned QMS paper is about. Together they're the same argument applied to two different parts of the same company.

Nida Uddin

Founder and CEO, UNMIRI

Building UNMIRI, a precision oncology infrastructure company with four product surfaces: cross-vendor NGS interpretation, genomics-aware decision support, oncology literature intelligence, and a free cross-vendor unification tool for clinicians. Writing here on architecture, clinical data, and HIPAA-ready AI.

See the NGS Interpretation API →

Advisors: Somdutta Saha, PhD, advises on technical architecture and bioinformatics methods as Technical and Scientific Advisor. On the clinical side, UNMIRI is in ongoing conversations with multiple board-certified pathologists about advisory roles. Public introductions land on the About page once each engagement is formalized and the advisor approves being named.